Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?

Area of Science:

• Immunology and Cardiovascular Science

Background:

• Cardiovascular disease (CVD) is a leading global cause of death.
• Chronic atherosclerosis, characterized by vascular inflammation and lipid metabolism disruption, is a primary driver of CVD.
• The immune system, encompassing innate and adaptive immunity, plays a critical role in atherosclerosis initiation and progression.

Purpose of the Study:

• To review the pathogenesis of CVD, focusing on atherosclerosis and the pro-atherogenic roles of immune cells.
• To highlight recent findings on the anti-atherogenic potential of B cell subsets.
• To explore how insights into immune pathogenesis can inform novel therapeutic strategies for arterial vascular inflammation.

Main Methods:

• Review of existing scientific literature and evidence correlating immunity with atherosclerosis.
• Analysis of the mechanisms by which lipoprotein retention triggers immune responses (Th1 cells, macrophages) in plaque formation.
• Synthesis of recent research on B cell subsets in atherosclerosis.

Main Results:

• Immune cells, including T helper type 1 (Th1) cells and macrophages, are integral to atherosclerotic plaque formation.
• Specific B cell subsets demonstrate potential anti-atherogenic properties.
• While current therapies targeting risk factors reduce mortality, novel treatments for vascular inflammation are needed.

Conclusions:

• Immune system dysregulation is central to the pathogenesis of atherosclerosis and CVD.
• Targeting immune pathways, including the roles of B cells, offers promising avenues for new CVD therapies.
• Further research into immune-mediated mechanisms can lead to innovative treatments to reduce cardiovascular mortality and morbidity.